A case of anaplastic thyroid carcinoma suffering from tracheoesophageal fistula and wound healing disorder of the gastrostomy site during lenvatinib therapy-Reference-Cited by-同舟云学术

A case of anaplastic thyroid carcinoma suffering from tracheoesophageal fistula and wound healing disorder of the gastrostomy site during lenvatinib therapy

Published:2024 Issue:1 Volume:34 Page:119-126
ISSN:1349-581X
Container-title:JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
language:en
Short-container-title:J Jpn Soc Head Neck Surg

Author:

Sueyoshi Shintaro¹,Ono Takeharu¹,Chitose Shun-ichi¹,Umeno Hirohito¹

Affiliation:

1. Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume

Publisher

Japan Society for Head and Neck Surgery

Link

https://www.jstage.jst.go.jp/article/jjshns/34/1/34_34.119/_pdf

Reference20 articles.

1. 1） Sugitani I, Miyauchi A, Sugino K, et al: Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC research Consortium of Japan Cohort Study of 677 Patients. World J Surg 36：1247-1254, 2012.

2. 2） Schlumberger M, Tahara M, Wirth LJ, et al: Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. NEJ 372：621-630, 2015 （SELECT）.

3. 3） Takahashi S, Tahara M, Kiyota N, et al: Phase Ⅱ study of lenvatinib in patient with differentiated, medullar and anaplastic thyroid cancer. J Clin Oncol 34：6088, 2016.

4. 4） Brose MS, Nutting CM, Jarzab B, et al: DECISION investigators, Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomized, dubleblind, phase 3 trial. Lancet 384：319-328, 2014.

5. 5）渡部達夫，小山則行：肝細胞がんに対するレンバチニブ（レンビマカプセル4mg）の抗腫瘍メカニズムと臨床試験成績．日薬理誌，153：242-248，2019.